Average Co-Inventor Count = 5.36
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (20 from 666 patents)
2. Quest Diagnostics Investments, Inc. (8 from 479 patents)
3. Incyte Holdings Corporation (7 from 147 patents)
4. Ceres, Inc. (2 from 214 patents)
30 patents:
1. 12083124 - Bicyclic heterocycles as FGFR inhibitors
2. 12084430 - Tricyclic urea compounds as JAK2 V617F inhibitors
3. 11959143 - MicroRNA profiling for diagnosis of dysplastic nevi and melanoma
4. 11607416 - Bicyclic heterocycles as FGFR inhibitors
5. 11421283 - Circulating microRNA as a marker for hepatocellular carcinoma
6. 11229631 - Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors
7. 10851424 - MicroRNA profiling for diagnosis of dysplastic nevi and melanoma
8. 10828290 - Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
9. 10722495 - Cyanoindazole compounds and uses thereof
10. 10517858 - Thiazolecarboxamides and pyridinecarboxamide compounds useful as PIM kinase inhibitors
11. 10422010 - Circulating microRNA as a marker for hepatocellular carcinoma
12. 10265307 - Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors
13. 10053738 - MicroRNA profiling for diagnosis of dysplastic nevi and melanoma
14. 9988689 - Microrna profiling for diagnosis of dysplastic nevi and melanoma
15. 9890162 - Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors